Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10451-10466
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Variable | OS (AGC = 3895), or (95%CI) | P value | OS (SRC = 1013), or (95%CI) | P value |
Age (yr) | < 0.001 | < 0.001 | ||
< 40 | 1 (Reference) | 1 (Reference) | ||
40-60 | 1.130 (0.882-1.447) | 0.333 | 1.267 (0.898-1.788) | 0.178 |
60-80 | 1.543 (1.212-1.985) | < 0.001 | 1.578 (1.123-2.218) | 0.009 |
> 80 | 2.936 (2.281-3.780) | < 0.001 | 2.290 (1.528-3.431) | < 0.001 |
Race | < 0.001 | < 0.001 | ||
White | 1 (Reference) | 1 (Reference) | ||
Black | 1.096 (0.973-1.234) | 0.133 | 1.326 (1.057-1.663) | 0.015 |
Black-AI | 1.382 (0.949-2.015) | 0.092 | 2.624 (1.423-4.838) | 0.002 |
Black-API | 0.726 (0.651-0.810) | < 0.001 | 0.800 (0.867-1.205) | 0.041 |
Sex | ||||
Male | 1 (Reference) | 1(Reference) | ||
Female | 0.964 (0.883-1.052) | 0.409 | 1.022 (0.867-1.205) | 0.791 |
Tumor size (cm) | < 0.001 | 0.001 | ||
< 2 | 1 (Reference) | 1 (Reference) | ||
2-5 | 1.026 (0.823-1.280) | 0.817 | 1.031 (0.680-1.565) | 0.885 |
> 5 | 1.211 (0.971-1.511) | 0.089 | 1.415 (0.930-2.152) | 0.105 |
AJCC stage | 0.019 | 0.028 | ||
I | 1 (Reference) | 1 (Reference) | ||
II | 1.227 (0.903-1.667) | 0.191 | 1.946 (0.923-4.102) | 0.080 |
III | 1.584 (1.076-2.330) | 0.020 | 3.050 (1.247-7.458) | 0.015 |
T stage | < 0.001 | < 0.001 | ||
T2 | 1 (Reference) | 1 (Reference) | ||
T3 | 1.384 (1.135-1.689) | 0.001 | 1.857 (1.189-2.899) | 0.006 |
T4 | 2.025 (1.633-2.512) | < 0.001 | 2.615 (1.644-4.161) | < 0.001 |
N stage | < 0.001 | 0.086 | ||
N0 | 1 (Reference) | 1 (Reference) | ||
N1 | 1.241 (1.056-1.459) | 0.009 | 1.061 (0.744-1.512) | 0.745 |
N2 | 1.295 (1.050-1.597) | 0.016 | 1.034 (0.665-1.608) | 0.881 |
N3 | 1.904 (1.549-2.341) | < 0.001 | 1.341 (0.882-2.037) | 0.170 |
Histology | 0.002 | |||
Differentiated | 1 (Reference) | |||
SRC | 1.276 (1.117-1.458) | < 0.001 | ||
Undifferentiated | 1.164 (1.037-1.306) | 0.010 | ||
SRC vs non-SRC | 1.139 (1.030-1.258) | 0.011 | ||
Adjuvant therapy | < 0.001 | |||
Radiotherapy | 0.635 (0.367-1.099) | 0.105 | ||
Chemotherapy | 0.481 (0.388-0.595) | < 0.001 | ||
Radiotherapy + Chemotherapy | 0.414 (0.334-0.512) | < 0.001 | ||
None | 1 (Reference) |
- Citation: Tian HK, Zhang Z, Ning ZK, Liu J, Liu ZT, Huang HY, Zong Z, Li H. Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma. World J Clin Cases 2022; 10(29): 10451-10466
- URL: https://www.wjgnet.com/2307-8960/full/v10/i29/10451.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i29.10451